CRP and posterior cortical atrophy: To the best of our knowledge, this is the first report showing that baseline circulating levels of CRP are associated with a higher risk of detecting PCa at the time of biopsy and demonstrating that circulating CRP levels could be used as a putative biomarker of PCa aggressiveness.